{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:37:51Z","timestamp":1793813871451,"version":"4.6.1"},"reference-count":65,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The atherogenic index of plasma (AIP), an emerging biomarker of lipid dysregulation, and high-sensitivity C-reactive protein (hs-CRP), an established marker of inflammation, are both implicated in the development of cardiovascular disease (CVD). However, their joint impact on CVD risk and the underlying mediation mechanisms remain unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study used data from the China Health and Retirement Longitudinal Study (CHARLS), including 8,763 adults aged \u226545 years with up to 9 years of follow-up. Baseline AIP and hs-CRP levels were measured, and participants were divided into four groups based on the AIP median and hs-CRP threshold (1 mg\/L). Multivariable Cox models assessed associations with CVD. Mediation analyses examined direct and indirect effects, including bidirectional mediation. Additive interaction was evaluated using the relative excess risk due to interaction (RERI), and predictive performance was assessed via Receiver Operating Characteristic Curve (ROC) curve analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 1,693 participants developed CVD during the follow-up period. Higher levels of AIP and hs-CRP were independently associated with CVD. Joint analysis showed that, compared with individuals with AIP below the median and hs-CRP &amp;lt;1 mg\/L, those with elevated levels of both AIP and hs-CRP had the highest risks of CVD (HR: 1.655; 95% CI: 1.455-1.883), heart disease (HR: 1.402; 95% CI: 1.207-1.628), and stroke (HR: 2.207; 95% CI: 1.771-2.749). These associations remained significant after adjustment for potential confounders, although the effect sizes were attenuated. Notably, the effect of hs-CRP on increased CVD risk was more pronounced among individuals with higher AIP levels. Mediation analysis revealed that hs-CRP mediated 6.6% of the association between AIP and CVD (\n                      <jats:italic>P<\/jats:italic>\n                      =0.042), while AIP mediated 20.3% of the association in the reverse pathway (\n                      <jats:italic>P<\/jats:italic>\n                      =0.008). The RERI between AIP and hs-CRP for CVD was 0.141 (95% CI: -0.102 to 0.384), suggesting a possible positive additive interaction. The ROC analysis indicated that the combined model had better predictive performance for CVD than either marker alone (AUC = 0.590), with the best performance observed in stroke prediction (AUC = 0.615). Subgroup analyses confirmed consistent associations across demographic and clinical subgroups, except in individuals with prediabetes or diabetes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Elevated levels of AIP and hs-CRP were independently and jointly associated with an increased risk of cardiovascular disease, particularly stroke. The observed mutual mediation effects and potential additive interaction suggest that lipid metabolism and inflammation may be interconnected in the pathophysiological processes underlying cardiovascular risk. These findings highlight the potential value of incorporating both biomarkers into cardiovascular risk assessment models to enhance early identification and prevention strategies among middle-aged and older adults.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2025.1618157","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T04:12:50Z","timestamp":1754453570000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Association of the atherogenic index of plasma and high-sensitivity C-reactive protein with incident cardiovascular disease: evidence from a national cohort of middle-aged and older Chinese adults"],"prefix":"10.3389","volume":"16","author":[{"given":"Ping-an","family":"Lian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-fei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan-fu","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan-zhan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao-jiao","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen-wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"399","DOI":"10.26599\/1671-5411.2023.06.001","article-title":"Report on cardiovascular health and diseases in China 2021: an updated summary","volume":"20","author":"In China","year":"2023","journal-title":"J Geriatr Cardiol"},{"key":"B3","first-page":"240","article-title":"Atherogenic Index of Plasma (AIP): A marker of cardiovascular disease","volume":"29","author":"Niroumand","year":"2015","journal-title":"Med J Islam Repub Iran"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.005873","article-title":"Discordance of low-density lipoprotein (LDL) cholesterol with alternative LDL-related measures and future coronary events","volume":"129","author":"Mora","year":"2014","journal-title":"Circulation"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1996.03540110036029","article-title":"A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction","volume":"276","author":"Stampfer","year":"1996","journal-title":"Jama"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.5603\/KP.a2015.0086","article-title":"Lipoprotein ratios are better than conventional lipid parameters in predicting coronary heart disease in Chinese Han people","volume":"73","author":"Zhu","year":"2015","journal-title":"Kardiol Pol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/s0009-9120(01)00263-6","article-title":"The plasma parameter log (TG\/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL))","volume":"34","author":"Dobi\u00e1sov\u00e1","year":"2001","journal-title":"Clin Biochem"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcmed.2019.08.009","article-title":"Atherogenic index of plasma: novel predictive biomarker for cardiovascular illnesses","volume":"50","author":"Fern\u00e1ndez-Mac\u00edas","year":"2019","journal-title":"Arch Med Res"},{"key":"B9","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/s12933-024-02370-4","article-title":"Association between atherogenic index of plasma and all-cause mortality and specific-mortality: a nationwide population\u2212based cohort study","volume":"23","author":"You","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s12933-023-01936-y","article-title":"Association between cumulative atherogenic index of plasma exposure and risk of myocardial infarction in the general population","volume":"22","author":"Zhang","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12933-024-02314-y","article-title":"Association between atherogenic index of plasma and new-onset stroke in individuals with different glucose metabolism status: insights from CHARLS","volume":"23","author":"Qu","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-021-01801-y","article-title":"The longitudinal effect of the atherogenic index of plasma on type 2 diabetes in middle-aged and older Chinese","volume":"59","author":"Yi","year":"2022","journal-title":"Acta Diabetol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12933-024-02144-y","article-title":"Association between atherogenic index of plasma control level and incident cardiovascular disease in middle-aged and elderly Chinese individuals with abnormal glucose metabolism","volume":"23","author":"Min","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12944-023-01853-9","article-title":"Association between atherogenic index of plasma and prehypertension or hypertension among normoglycemia subjects in a Japan population: a cross-sectional study","volume":"22","author":"Tan","year":"2023","journal-title":"Lipids Health Dis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"9900","DOI":"10.1038\/s41598-021-89307-z","article-title":"Atherogenic index of plasma as predictors for metabolic syndrome, hypertension and diabetes mellitus in Taiwan citizens: a 9-year longitudinal study","volume":"11","author":"Li","year":"2021","journal-title":"Sci Rep"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2013an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000079160.07364.6A","article-title":"C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly: the Cardiovascular Health Study","volume":"108","author":"Cao","year":"2003","journal-title":"Circulation"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032804","article-title":"C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease","volume":"350","author":"Danesh","year":"2004","journal-title":"N Engl J Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa099","article-title":"Targeting cardiovascular inflammation: next steps in clinical translation","volume":"42","author":"Lawler","year":"2021","journal-title":"Eur Heart J"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1001\/jama.297.6.611","article-title":"Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score","volume":"297","author":"Ridker","year":"2007","journal-title":"Jama"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/JCI92035","article-title":"Inflammatory mechanisms linking obesity and metabolic disease","volume":"127","author":"Saltiel","year":"2017","journal-title":"J Clin Invest"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1097\/MOL.0000000000000051","article-title":"Hyperlipidemia and cardiovascular disease: inflammation, dyslipidemia, and atherosclerosis","volume":"25","author":"Tietge","year":"2014","journal-title":"Curr Opin Lipidol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.01.072","article-title":"Chlamydia and lipids engage a common signaling pathway that promotes atherogenesis","volume":"71","author":"Chen","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s11356-021-14109-9","article-title":"Management of oxidative stress and inflammation in cardiovascular diseases: mechanisms and challenges","volume":"28","author":"Donia","year":"2021","journal-title":"Environ Sci pollut Res Int"},{"key":"B25","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1042\/CS20080106","article-title":"High-density lipoproteins, inflammation and oxidative stress","volume":"116","author":"Tabet","year":"2009","journal-title":"Clin Sci (Lond)"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.909151","article-title":"Triglyceride and triglyceride-rich lipoproteins in atherosclerosis","volume":"9","author":"Zhang","year":"2022","journal-title":"Front Mol Biosci"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dys203","article-title":"Cohort profile: the China health and retirement longitudinal study (CHARLS)","volume":"43","author":"Zhao","year":"2014","journal-title":"Int J Epidemiol"},{"key":"B28","volume-title":"China Health and Retirement Longitudinal Study: 2011\u20132012 National Baseline User\u2019s Guide","author":"Zhao","year":"2013"},{"key":"B29","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s13195-021-00923-3","article-title":"High-intensity physical activity is not associated with better cognition in the elder: evidence from the China Health and Retirement Longitudinal Study","volume":"13","author":"Wu","year":"2021","journal-title":"Alzheimers Res Ther"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwz170","article-title":"Venous blood-based biomarkers in the China health and retirement longitudinal study: rationale, design, and results of the 2015 wave","volume":"188","author":"Chen","year":"2019","journal-title":"Am J Epidemiol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.11.037","article-title":"A test in context: high-sensitivity C-reactive protein","volume":"67","author":"Ridker","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/oby.20995","article-title":"Lower BMI cutoffs to define overweight and obesity in China","volume":"23","author":"He","year":"2015","journal-title":"Obes (Silver Spring)"},{"key":"B33","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.1186\/s12889-024-20743-y","article-title":"Prevalence and association of sleep duration and different volumes of physical activity with type 2 diabetes: the first evidence from CHARLS","volume":"24","author":"Zhou","year":"2024","journal-title":"BMC Public Health"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000075790.33892.AE","article-title":"Seventh report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7): resetting the hypertension sails","volume":"41","author":"Lenfant","year":"2003","journal-title":"Hypertension"},{"key":"B35","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.2337\/dc20-S002","article-title":"2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2020","volume":"43","year":"2020","journal-title":"Diabetes Care"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"B37","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12877-023-03823-3","article-title":"Development and validation of a risk prediction model for frailty in patients with diabetes","volume":"23","author":"Bu","year":"2023","journal-title":"BMC Geriatr"},{"key":"B38","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12933-022-01522-8","article-title":"Association of the atherogenic index of plasma with cardiovascular risk beyond the traditional risk factors: a nationwide population-based cohort study","volume":"21","author":"Kim","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1186\/s12933-023-02044-7","article-title":"Relationship between the cumulative exposure to atherogenic index of plasma and ischemic stroke: a retrospective cohort study","volume":"22","author":"Zheng","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12944-019-1112-6","article-title":"Atherogenic index of plasma is a novel and strong predictor associated with fatty liver: a cross-sectional study in the Chinese Han population","volume":"18","author":"Xie","year":"2019","journal-title":"Lipids Health Dis"},{"key":"B41","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12944-018-0656-1","article-title":"Atherogenic index of plasma is an effective index for estimating abdominal obesity","volume":"17","author":"Shen","year":"2018","journal-title":"Lipids Health Dis"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcd.2014.03.007","article-title":"Meta-analysis of Atherogenic Index of Plasma and other lipid parameters in relation to risk of type 2 diabetes mellitus","volume":"9","author":"Zhu","year":"2015","journal-title":"Prim Care Diabetes"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.2020.1838138","article-title":"Usefulness of atherogenic index of plasma for estimating reduced eGFR risk: insights from the national health and nutrition examination survey","volume":"133","author":"Zhou","year":"2021","journal-title":"Postgrad Med"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.P011668","article-title":"Cholesterol esterification and atherogenic index of plasma correlate with lipoprotein size and findings on coronary angiography","volume":"52","author":"Dobi\u00e1sov\u00e1","year":"2011","journal-title":"J Lipid Res"},{"key":"B45","doi-asserted-by":"publisher","first-page":"105351","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105351","article-title":"The atherogenic index of plasma is independently associated with symptomatic carotid artery stenosis","volume":"29","author":"Garg","year":"2020","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2010.03.047","article-title":"Oxidized LDL in human carotid plaques is related to symptomatic carotid disease and lesion instability","volume":"52","author":"Sigala","year":"2010","journal-title":"J Vasc Surg"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-018-0064-2","article-title":"Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty","volume":"15","author":"Ferrucci","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1161\/CIRCULATIONAHA.104.504159","article-title":"C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the cardiovascular health study","volume":"112","author":"Cushman","year":"2005","journal-title":"Circulation"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000097109.90783.FC","article-title":"Inflammatory markers and onset of cardiovascular events: results from the Health ABC study","volume":"108","author":"Cesari","year":"2003","journal-title":"Circulation"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61717-7","article-title":"C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis","volume":"375","author":"Kaptoge","year":"2010","journal-title":"Lancet"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-151-7-200910060-00009","article-title":"C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Force","volume":"151","author":"Buckley","year":"2009","journal-title":"Ann Intern Med"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14730","article-title":"Does reproductive stage impact cardiovascular disease risk factors? Results from a population-based cohort in Lausanne (CoLaus study)","volume":"97","author":"Raguindin","year":"2022","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.08.1043","article-title":"Inflammation, immunity, and infection in atherothrombosis: JACC review topic of the week","volume":"72","author":"Libby","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1161\/hc0902.104353","article-title":"Inflammation and atherosclerosis","volume":"105","author":"Libby","year":"2002","journal-title":"Circulation"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.10.065","article-title":"Pathology of the vulnerable plaque","volume":"47","author":"Virmani","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s12933-023-01878-5","article-title":"Supra-additive effect of chronic inflammation and atherogenic dyslipidemia on developing type 2 diabetes among young adults: a prospective cohort study","volume":"22","author":"Lan","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.jacc.2013.05.016","article-title":"High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link","volume":"62","author":"Yousuf","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1093\/aje\/kwv144","article-title":"Low-density lipoprotein cholesterol concentrations and association of high-sensitivity C-reactive protein concentrations with incident coronary heart disease in the multi-ethnic study of atherosclerosis","volume":"183","author":"Lin","year":"2016","journal-title":"Am J Epidemiol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1397836","article-title":"Editorial: Oxidative stress and inflammation in cardiometabolic disorders","volume":"15","author":"Klisic","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1374584","article-title":"Editorial: The role of oxidative stress in metabolic and inflammatory diseases","volume":"15","author":"Klisic","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B61","doi-asserted-by":"publisher","first-page":"110348","DOI":"10.1016\/j.abb.2025.110348","article-title":"The impact of oxidative stress on abnormal lipid metabolism-mediated disease development","volume":"766","author":"Li","year":"2025","journal-title":"Arch Biochem Biophys"},{"key":"B62","doi-asserted-by":"publisher","first-page":"113707","DOI":"10.1016\/j.intimp.2024.113707","article-title":"Isoferulic acid regulates CXCL12\/CXCR4-mediated apoptosis and autophagy in podocyte and mice with STZ-induced diabetic nephropathy","volume":"144","author":"Liu","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1007\/s13105-024-01060-9","article-title":"Modification of adipogenesis and oxidative stress by quercetin: positive or negative impact on adipose tissue metabolism of obese diabetic Zucker rats","volume":"81","author":"K\u0159skov\u00e1","year":"2025","journal-title":"J Physiol Biochem"},{"key":"B64","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1053\/j.gastro.2024.12.012","article-title":"In Obesity, Esophagogastric junction fat impairs esophageal barrier function and dilates intercellular spaces via hypoxia-inducible factor 2\u03b1","volume":"168","author":"Paris","year":"2025","journal-title":"Gastroenterology"},{"key":"B65","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1177\/2047487319880041","article-title":"Risk and management of pre-diabetes","volume":"26","author":"Beulens","year":"2019","journal-title":"Eur J Prev Cardiol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1618157\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T04:12:52Z","timestamp":1754453572000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1618157\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,6]]},"references-count":65,"alternative-id":["10.3389\/fendo.2025.1618157"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1618157","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,6]]},"article-number":"1618157"}}